Gruenenthal Gmbh

Basf Aktiengesellschaft

Grunenthal Gmbh

Fritz Theil

Werner Guenter Englberger

Klaus Linz

Bert Nolte

Saskia Zemolka

Olga Groeger

Bernd Sundermann

Stefan Schunk

Hans Schick

Melanie Reich

Beatrix Merla

Wolfgang Schröder

Karl Siemensmeyer

Gregor Bahrenberg

Babette-Yvonne Koegel

Stefan Oberboersch

Ruth Jostock

Helmut Sonnenschein

Paul Ratcliffe

Birgit Braun

Stephanie Harlfinger

Timo Struenker

Hagen-Heinrich Hennies

Robert Frank

Oswald K Zimmer

Helmut Buschmann

Derek John Saunders

Sven Kühnert

Heinz Graubaum

Edward Bijsterveld

Anita Wegert

Tieno Germann

Sven Kuehnert

Sabine Hees

Stefanie Frosch

Birgitta Henkel

Utz-Peter Jagusch

Sven Frormann

Rene Michael Koenigs

Carsten Griebel

Stefan Oberbörsch

Babette-Yvonne Kögel

Carsten Tschierske

René Michael Koenigs

Birgit Roloff

Jens Kaufmann

Rene Kudick

Julian Gebauer

Detley Joachimi

Timo Strünker

Olga GRÖGER

Brigitta Henkel

Wolfgang Schröber

The invention relates to substituted spirocyclic cyclohexane derivatives which have an affinity for the &#x3bc; opioid receptor and/or the ORL1 receptor, processes for the preparation thereof, medicaments containing these compounds and the use of these compounds for the preparation of medicaments.

Substituted azaspiro(4.5)decane derivatives

The invention relates to substituted spirocyclic cyclohexane derivatives which have an affinity for the &#x3bc; opioid receptor and the ORL1 receptor, processes for the preparation thereof, medicaments containing these compounds and the use of these compounds for the preparation of medicaments.

The invention relates to compounds that have an affinity to the &#x3bc;-opioid receptor and the ORL 1-receptor, methods for their production, medications containing these compounds and the use of these compounds for the treatment of pain or other conditions.

Substituted cyclohexyldiamines

The invention relates to compounds which have an affinity for the &#x3bc; opioid receptor and the ORL1 receptor, processes for the preparation thereof, medicaments containing these compounds and the use of these compounds for the preparation of medicaments.

Hydroxymethylcyclohexylamines

The invention relates to compounds that have an affinity to the &#x3bc;-opioid receptor and the ORL 1-receptor, methods for their production, medications containing these compounds and the use of these compounds for the treatment of pain and other conditions.

Spiro(5.5)undecane derivatives

The present invention relates to salts of substituted allophanates, methods for their production, medicaments containing said compounds and the use of said compound for the production of medicaments.

Salts of substituted allophanates and their use in drugs

Substituted sulfonamide compounds corresponding to formula I pharmaceutical compositions comprising them, a process for preparing them, and the use of such compounds to treat or inhibit pain and other disorders or disease states.

Substituted sulfonamide compounds

Substituted amide compounds corresponding to formula I: processes for preparing them, pharmaceutical compositions containing these compounds, and the use of substituted amide derivatives for the preparation of medicaments for the treatment of pain and various other conditions.

Substituted amide compounds

Piperidine-2,6-diones heterocyclically substituted in the 3-position corresponding to formula I Also the production and use of such compounds in pharmaceutical formulations and related methods of treatment.

Piperidine-2,6-diones heterocyclically substituted in the 3-position

The chiral group of the formula ##STR1## is used as a constituent of liquid-crystalline compounds.

Use of the chiral group (1S, 4R)-1,4-dihydroxy-2-cyclopentenyl in the

Growing community of inventors

Berlin, Germany

Fritz Theil